Cipla Ltd.
BSE: 500087 | NSE: CIPLA
Large Cap | Pharmaceuticals & Drugs
1426.80
-11.95 (-0.83%) Cipla - Quaterly Results
Date: 25-01-2022
The December 2021 quarter revenue stood at Rs. 39547.90 millions, up 5.98% as compared to Rs. 37315.50 millions during the corresponding quarter last year.Profit after tax improved marginally to Rs. 7308.30 millions for the quarter ended December 2021 from Rs. 6989.30 millions of corresponding previous quarter.The company reported a good operating profit of 11129.80 millions compared to 10922.70 millions of corresponding previous quarter.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202112 | 202012 | % Var | 202112 | 202012 | % Var | 202103 | 202003 | % Var | |
| Sales | 39547.90 | 37315.50 | 5.98 | 119072.30 | 106674.60 | 11.62 | 139005.80 | 126591.50 | 9.81 |
| Other Income | 730.00 | 961.20 | -24.05 | 3503.90 | 1809.50 | 93.64 | 2302.80 | 8928.50 | -74.21 |
| PBIDT | 11129.80 | 10922.70 | 1.90 | 35186.80 | 32528.10 | 8.17 | 39518.40 | 36001.40 | 9.77 |
| Interest | 55.50 | 103.30 | -46.27 | 211.50 | 362.30 | -41.62 | 450.70 | 360.50 | 25.02 |
| PBDT | 11074.30 | 10819.40 | 2.36 | 34975.30 | 32165.80 | 8.73 | 39067.70 | 35640.90 | 9.61 |
| Depreciation | 1339.50 | 1345.70 | -0.46 | 4099.00 | 4191.00 | -2.20 | 5561.10 | 5997.80 | -7.28 |
| PBT | 9734.80 | 9473.70 | 2.76 | 30876.30 | 27974.80 | 10.37 | 33506.60 | 29643.10 | 13.03 |
| TAX | 2426.50 | 2484.40 | -2.33 | 7826.60 | 7426.10 | 5.39 | 8823.80 | 6461.40 | 36.56 |
| Deferred Tax | -159.10 | -31.60 | 403.48 | -276.40 | -290.90 | -4.98 | -220.00 | 1001.80 | -121.96 |
| PAT | 7308.30 | 6989.30 | 4.56 | 23049.70 | 20548.70 | 12.17 | 24682.80 | 23181.70 | 6.48 |
| Equity | 1613.60 | 1612.90 | 0.04 | 1613.60 | 1612.90 | 0.04 | 1612.90 | 1612.50 | 0.02 |
| PBIDTM(%) | 28.14 | 29.27 | -3.86 | 29.55 | 30.49 | -3.09 | 28.43 | 28.44 | -0.03 |